B20 Share Price

Open 0.83 Change Price %
High 0.83 1 Day 0.02 2.47
Low 0.82 1 Week 0.00 0.00
Close 0.83 1 Month 0.00 0.00
Volume 1447600 1 Year 0.00 0.00
52 Week High 0.03
52 Week Low 0.02
B20 Important Levels
Resistance 2 0.84
Resistance 1 0.84
Pivot 0.83
Support 1 0.82
Support 2 0.82
SGX Singapore Most Active Stocks
N21 131.00 0.00%
A50 0.13 0.00%
A50 0.13 0.00%
5DE 0.02 0.00%
576 0.15 0.00%
EG0 0.03 0.00%
C8R 0.06 0.00%
B22 0.09 0.00%
5ME 0.20 0.00%
E5H 0.40 0.00%
More..
SGX Singapore Top Gainers Stocks
A6F 0.24 2300.00%
C11 0.12 1100.00%
A69 0.09 800.00%
T16 0.19 533.33%
A10 0.04 300.00%
L05 0.04 300.00%
X27 0.08 100.00%
D2V 0.06 100.00%
D2V 0.06 100.00%
L18 0.02 100.00%
More..
SGX Singapore Top Losers Stocks
5BM 0.01 -90.91%
P82 0.01 -87.50%
B2X 0.04 -83.33%
B2X 0.04 -83.33%
A54 0.07 -46.15%
F18 0.03 -40.00%
A18 0.09 -35.71%
C37 0.02 -33.33%
Y07 0.03 -25.00%
A02 0.04 -20.00%
More..

Biosensors International (SGX: B20)

B20 Technical Analysis 5
As on 4th Apr 2016 B20 Share Price closed @ 0.83 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.77 & Strong Buy for SHORT-TERM with Stoploss of 0.81 we also expect STOCK to react on Following IMPORTANT LEVELS.
B20 Target for November
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
B20 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.biosensors.com
B20 Address
B20
Kaki Bukit Avenue 1
Block 10
Singapore, 417942
Singapore
Phone: 65 6213 5777
Fax: 65 6213 5737
B20 Latest News
Interactive Technical Analysis Chart Biosensors International ( B20 SGX Singapore )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Biosensors International
B20 Business Profile
Biosensors International Group, Ltd., an investment holding company, engages in the research and development, manufacture, assembly, marketing, distribution, and sale of medical devices for interventional cardiology and critical care procedures worldwide. It operates through three segments: Interventional Cardiology, Critical Care, and Licensing Revenue. The Interventional Cardiology segment supplies its proprietary drug-eluting stent products, coronary bare-metal stents, accompanying stent delivery balloon catheter systems, angioplasty balloons, and catheters under the BioMatrix Flex, BioMatrix NeoFlex, Axxess, BioFreedom, Gazelle, and Powerline brand names. The Critical Care segment supplies catheter systems and related accessories that are used in surgeries, and intensive care treatment and monitoring procedures. It offers its products under the ACCUTRANS, BIOTRANS, and BIOTRAY brand names. The Licensing Revenue segment engages in the licensing of its proprietary drug-eluting stent technology and intellectual property. The company was founded in 1990 and is headquartered in Singapore.